WuXi Biologics Receives 2023 ISPE Facility of the Year Award for Operations

DUNDALK, Ireland, May 22, 2023 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that the International Society for Pharmaceutical Engineering (ISPE) has awarded the company a 2023 Facility of the Year Award (FOYA) in the Operations category. WuXi Biologics was recognized for using innovative … Read more

CORVIA MEDICAL RELEASES TWO-YEAR CLINICAL TRIAL RESULTS CONFIRMING SUSTAINED BENEFIT AND SAFETY OF ITS ATRIAL SHUNT IN HEART FAILURE PATIENTS

FIRST-EVER PHASE III RANDOMIZED CONTROLLED TRIAL OF ATRIAL SHUNT THERAPY SHOWS CONTINUED PROMISE TEWKSBURY, Mass., May 22, 2023 /PRNewswire/ — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced two-year results from its REDUCE LAP-HF II randomized clinical trial confirming safety and sustained efficacy of the Corvia® Atrial Shunt … Read more

Conference held to foster digital, AI-driven life and health industry development in Wuxi, E. China

BEIJING, May 22, 2023 /PRNewswire/ — The 2023 Taihu Bay Future Healthcare Conference (2023 TBHC) was held on Thursday in Wuxi City in east China’s Jiangsu Province to better integrate with digitalization and artificial intelligence (AI) to enable local life and health industry development. With “innovation and opening, digital intelligence and health” as the theme, … Read more

TVM Capital Healthcare Announces Euro 10 Million Investment in DEBx Medical

DEBx Medical is innovating the management of chronic wounds, improving the life of millions of patients – the investment will enable the company to expand its global footprint and build a presence in the MENA region DUBAI, UAE and AMSTERDAM , May 22, 2023 /PRNewswire/ — TVM Capital Healthcare, a global specialist healthcare private equity firm … Read more

TVM Capital Healthcare gibt Investition von 10 Mio. EUR in DEBx Medical bekannt

DEBx Medical ist ein innovatives Unternehmen im Bereich der Behandlung chronischer Wunden, das das Leben von Millionen von Patienten verbessert. Die Investition wird es dem Unternehmen ermöglichen, seine internationale Präsenz zu erweitern und eine Repräsentanz in der MENA-Region aufzubauen  DUBAI, VAE, und AMSTERDAM, 22. Mai 2023 /PRNewswire/ — TVM Capital Healthcare, eine weltweit tätige Private-Equity-Firma … Read more

Shenzhen SiBionics Co., Ltd. beantragt die CE-Zertifizierung für SIBIONICS CGM

Hunderte von Millionen Diabetikern profitieren davon SHENZHEN, China, 22. Mai 2023 /PRNewswire/ — Shenzhen SiBionics Co., Ltd. hat angekündigt, die CE-Zertifizierung zu beantragen, in der Hoffnung, dass SIBIONICS CGM mehr Diabetes-Patienten und medizinischen Einrichtungen zugute kommt, indem es ihnen eine bessere Erfahrung bei der Blutzuckermessung sowie verfeinerte und personalisierte Gesundheitslösungen bietet und zu Chinas Stärke im … Read more

Shenzhen SiBionics Co., Ltd. solicitará la certificación CE para SIBIONICS CGM

Beneficia a cientos de millones de diabéticos SHENZHEN, China, 22 de mayo de 2023 /PRNewswire/ — Shenzhen SiBionics Co., Ltd. ha anunciado que está solicitando la certificación CE, con la esperanza de hacer que SIBIONICS CGM beneficie a más pacientes con diabetes e instituciones médicas, ofreciéndoles una mejor experiencia de monitorización de la glucosa en … Read more

Serca Pharmaceuticals showcases exciting data on 13-M at Heart Failure 2023

First-in-class, cardioprotective drug with potential to transform treatment following myocardial infarction and stenting OSLO, Norway, May 22, 2023 /PRNewswire/ — Serca Pharmaceuticals, a Cardioprotection company that is developing 13-M, a novel first in class treatment for minimising tissue damage that occurs with blood reperfusion post myocardial infarction (MI) and stenting, today announces that it presented data … Read more

Gravyty’s first annual Gforce conference brings together hundreds of like-minded engagement and fundraising professionals

ORLANDO, Fla., May 22, 2023 /PRNewswire/ — Gravyty held the first-ever Gforce, an annual conference that connects, educates and inspires engagement and fundraising professionals throughout education and nonprofit industries at Disney’s Swan and Dolphin Hotel April 30 through May 3, 2023. The event brought together hundreds of professionals who work in fundraising, alumni engagement, member … Read more

Shenzhen SiBionics Co., Ltd. to apply for CE certification for SIBIONICS CGM

Benefits Hundreds of Millions of Diabetics SHENZHEN, China, May 22, 2023 /PRNewswire/ —  Shenzhen SiBionics Co., Ltd. has announced it is applying for CE certification, hoping to make SIBIONICS CGM benefit more diabetes patients and medical institutions, bringing them a better blood glucose monitoring experience, as well as refined and personalized health solutions, and contribute China’s … Read more